Filing Details
- Accession Number:
- 0001570523-18-000005
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2018-03-28 19:07:59
- Reporting Period:
- 2017-12-31
- Accepted Time:
- 2018-03-28 19:07:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1559356 | Immune Therapeutics Inc. | IMUN | Pharmaceutical Preparations (2834) | 593226705 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1570523 | Jackman Robert Dailey | 401 First Street Los Altos CA 94022 | No | No | No | Yes |
Transaction Summary
| Purchased: | 151,700 shares | Avg. Price: $0.06 | Total Value: $9,559.00 |
| Number of Shares After Transactions: | 22,059,859 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-04-13 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-13 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-13 | 5,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-19 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-19 | 1,000 | $0.06 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 11,000 | $0.06 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 2,000 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,700 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,250 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 15,050 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 9,079 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,250 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,250 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,250 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,250 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,250 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 1,250 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 28,000 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 39,121 | $0.07 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-06 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-11 | 2,000 | $0.06 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 10,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-23 | 2,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 5,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-24 | 1,000 | $0.05 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-25 | 2,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-29 | 1,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-09-01 | 2,000 | $0.04 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-09-12 | 1,000 | $0.03 | 22,059,859 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Billionaire Hedge Funds
